Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks
That's a normal letter that gets sent out, they have 6 months!
They're getting bought out for the shell or cash
They won't R/S, they are done and trying to sell/merge not continue trials
Watts up buddy? I'm glad this finally left the teens for you. Hope you aren't loading up here
Halted again pending news ??
.04 is already pretty cheap
Off to the races
Who said I did?! Played those to .12
I've kept a short term trade and long holdings for about 8 years now
I'm back in! Just got 10,000 @.279.
After some sort of results released, hope to ride and not hit by.
"They" don't want this past .295. Nice to see us past .09 for all the long longs. Watts, whattup?!
Results in June
Ready to run again
Been long for 7 years. :fu
Lol, I was joking. Don't live life so serious
Maybe with a 100-1 reverse split
Best stock to trade
Yup. I've got some shares from way back at $8 and been playing the swings in the meantime to recoup. Make or break with upcoming approval
$$$$$
Well, we aren't making money yet so I don't really see it as a huge boost. People usually sell into earnings.
Financials Thursday, definitely red tomorrow one would think
Yup :)
We're due. It hits $1.50 every 3 months but with approval around the corner...weeeeee
It has :) Was talking about the board
Wake up!
Watts, what's up buddy? Glad to see after the .05's we're in the .20's and holding
Hope you didn't sleep today!
You all might want to hop on NEOT today
Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
GlobeNewswire•December 23, 2016
SAN DIEGO, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of submental subcutaneous fat.
“The initiation of our Phase 2 proof of concept trial for LIPO-202 for the reduction of submental fat is a significant milestone for Neothetics,” said Kim Kamdar, Ph.D., a member of Neothetics’ Operating Committee and Board of Directors. “We continue to believe LIPO-202 could have exceptional impact in the submental fat reduction market.”
LIPO-202-CL-31 is a multi-center, randomized, double-blind, placebo-controlled Phase 2 proof of concept trial to assess the safety and efficacy of two doses of LIPO-202 versus placebo for the reduction of submental bulging due to subcutaneous fat. The trial is expected to enroll a total of 150 patients at approximately ten sites across the United States. Subjects will receive up to 30 subcutaneous injections of LIPO-202 or placebo once a week for eight weeks. Subjects will be randomized 1:1:1 and receive either 0.3 mcg, or 3.0 mcg dose of LIPO-202, or placebo. Follow up visits to access safety and efficacy will occur one week and four weeks post the last treatment.
The study endpoints include both safety and efficacy measurements. Efficacy measures will assess improvement in the patient’s submental region as evaluated by both the patient and clinician, overall patient satisfaction and evaluation of submental fat thickness by calipers.
The company expects to report top-line data from this trial in late second quarter 2017.
More information about the Neothetics trials and participating sites is available by visiting www.clinicaltrials.gov.
Phase 2 initiated today
Nice to see this popping for the longs, finally
Shit, sorry to hear.
So if we have common we should 100% sell ASAP? Why is anyone even trading the stock then? I'm currently down $3K and my holdings worth $78 lol.
If I knew the answer to #1 I'd be $20K more wealthy
The phase 3 failed miserably though. I have a ton at $8. Hope they made substantial changes to the compound.
Hopefully the redo on phase 3 passes. ZLTQ is the only real competition
We got crushed from a failed phase 3 of the main product in December tanking from $12 to sub $1. You know that right?